Inhibition of PAR-1 activation by either gene knockout or pharmaceutical inhibitors is protective in MPTP-induced dopaminergic neural terminal damage in a mouse Parkinson’s disease model [14], which is consistent with our observations. The gene discussed is F2R; the disease is Parkinson disease.